Median-Based Incremental Cost-Effectiveness Ratio (ICER)

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

Milton C. Weinstein, William B. Stason · New England Journal of Medicine · 1977 · 2.1K citations

Pharmacy, Health Policy, Pharmacoeconomics +17

Smearing Estimate: A Nonparametric Retransformation Method

Naihua Duan · Journal of the American Statistical Association · 1983 · 2.1K citations

Social Sciences, Economics, Insurance +14

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

I. F. Tannock, David Osoba, Martin R. Stockler et al. · Journal of Clinical Oncology · 1996 · 1.6K citations

Medicine, Oncology, Pharmacotherapy +17

Recommendations for Reporting Cost-effectiveness Analyses

Joanna E. Siegel · JAMA · 1996 · 1.2K citations

Pharmacy, Health Administration, Health Policy +10

Representing uncertainty: the role of cost‐effectiveness acceptability curves

Elisabeth Fenwick, Karl Claxton, Mark Sculpher · Health Economics · 2001 · 1.1K citations

Pharmacy, Pharmacoeconomics, Decision Analysis +14